Ultragenyx Pharmaceutical (RARE) EBT (2013 - 2026)
Ultragenyx Pharmaceutical's EBT came in at -$91 million for Q2 2026, compared with -$114 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) EBT (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ultragenyx Pharmaceutical reported EBT of -$582.23 million; for FY2025, it came in at -$571 million.
- Going back by year, EBT was -$567 million in FY2024, -$609 million in FY2023, -$701.73 million in FY2022 and -$452.98 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBT since Q3 2021.
- Business Quant data shows RARE's EBT at -$184 million (Q1 2026), -$127.69 million (Q4 2025) and -$179.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn | -91.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.00 Mn |
| Mar 31, 2026 | -184.00 Mn |
| Dec 31, 2025 | -127.69 Mn |
| Sep 30, 2025 | -179.54 Mn |
| Jun 30, 2025 | -114.00 Mn |
| Mar 31, 2025 | -150.00 Mn |
| Dec 31, 2024 | -132.82 Mn |
| Sep 30, 2024 | -133.21 Mn |
| Jun 30, 2024 | -130.74 Mn |
| Mar 31, 2024 | -170.23 Mn |
| Dec 31, 2023 | -127.43 Mn |
| Sep 30, 2023 | -159.00 Mn |
| Jun 30, 2023 | -159.10 Mn |
| Mar 31, 2023 | -163.48 Mn |
| Dec 31, 2022 | -153.28 Mn |
| Sep 30, 2022 | -238.82 Mn |
| Jun 30, 2022 | -157.86 Mn |
| Mar 31, 2022 | -151.76 Mn |
| Dec 31, 2021 | -122.44 Mn |
| Sep 30, 2021 | -72.82 Mn |
API Access
Ultragenyx Pharmaceutical EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();